FUSION BIOVENTURE

Serial Number 97276885
Registration 7011432
700

Registration Progress

Application Filed
Feb 21, 2022
Under Examination
Approved for Publication
Jan 10, 2023
Published for Opposition
Jan 10, 2023
Registered
Mar 28, 2023

Trademark Image

FUSION BIOVENTURE

Basic Information

Serial Number
97276885
Registration Number
7011432
Filing Date
February 21, 2022
Registration Date
March 28, 2023
Published for Opposition
January 10, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 28, 2023
Registration
Registered
Classes
036 042

Rights Holder

Fosun Pharma USA Inc.

03
Address
91 Hartwell Avenue
Lexington, MA 02421

Ownership History

Fosun Pharma USA Inc.

Original Applicant
03
Lexington, MA

Fosun Pharma USA Inc.

Owner at Publication
03
Lexington, MA

Fosun Pharma USA Inc.

Original Registrant
03
Lexington, MA

Legal Representation

Attorney
Perry Gattegno

USPTO Deadlines

Next Deadline
1248 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-03-28)
Due Date
March 28, 2029
Grace Period Ends
September 28, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
Mar 28, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 28, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 10, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 10, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 21, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 6, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 5, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 24, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 24, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 036
Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies
First Use Anywhere: 20200900
First Use in Commerce: 20200900
Class 042
Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development
First Use Anywhere: 20200900
First Use in Commerce: 20200900

Classification

International Classes
036 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOVENTURE"